Ind. Code § 12-21-9-1 "Fund"
Sec. 1. As used in this chapter, "fund" refers to the therapeutic psilocybin and ibogaine research fund established by section 4 of this chapter.
As added by P.L.152-2024, SEC.4. Amended by P.L.213-2025, SEC.123.
Ind. Code ch. 12-21-9
Ind. Code ch. 12-21-9
in effectInd. Code § 12-21-9-1.5 "Ibogaine"
Sec. 1.5. (a) As used in this chapter, "ibogaine" means a naturally occurring psychoactive compound found in the root bark of the iboga.
(b) The term includes ibogaine.
As added by P.L.213-2025, SEC.124.
Ind. Code § 12-21-9-2 "Psilocybin"
Sec. 2. (a) As used in this chapter, "psilocybin" means a naturally occurring psychedelic prodrug compound that is produced by fungi, including members of the genus psilocybe.
(b) The term includes psilocin.
As added by P.L.152-2024, SEC.4.
Ind. Code § 12-21-9-3 "Research institution"
Sec. 3. As used in this chapter, "research institution" refers to an organization that meets all of the following:
(1) Has an academic institution that operates an institutional review board (IRB) that oversees research.
(2) Publishes the results of previous clinical trials in peer reviewed publications.
(3) Has access to a clinical research center and the center's resources, including research dedicated medical staff.
As added by P.L.152-2024, SEC.4.
Ind. Code § 12-21-9-4 Therapeutic psilocybin and ibogaine research fund
Sec. 4. The therapeutic psilocybin and ibogaine research fund is established for the purpose of providing financial assistance to research institutions in Indiana to study, in accordance with the requirements established in section 7 of this chapter, the use of psilocybin and ibogaine to treat mental health and other medical conditions.
As added by P.L.152-2024, SEC.4. Amended by P.L.213-2025, SEC.125.
Ind. Code § 12-21-9-5 Administration; expenses
Sec. 5. (a) The fund shall be administered by the division.
(b) The expenses of administering the fund shall be paid from money in the fund.
As added by P.L.152-2024, SEC.4.
Ind. Code § 12-21-9-6 Sources of funds; investment; nonreverting fund; appropriation
Sec. 6. (a) The fund consists of:
(1) money received from state or federal grants or programs; and
(2) gifts, money, and donations received from any other source, including transfers from other funds or accounts.
(b) The treasurer of state shall invest the money in the fund not currently needed to meet the obligations of the fund in the same manner as other public money may be invested. Interest that accrues from these investments shall be deposited in the fund.
(c) Money in the fund at the end of a state fiscal year does not revert to the state general fund.
(d) Money in the fund is continuously appropriated for purposes of this chapter.
As added by P.L.152-2024, SEC.4.
Ind. Code § 12-21-9-7 Application; clinical study requirements
Sec. 7. (a) A research institution in Indiana may apply to the division to receive financial assistance from the fund to conduct one (1) or more clinical studies to evaluate the efficacy of psilocybin and ibogaine as an alternative treatment for mental health and other medical conditions, including the following:
(1) Posttraumatic stress disorder, with a focus on treating the disorder in combat veterans and first responders.
(2) Anxiety.
(3) Depression.
(4) Bipolar disorder.
(5) Chronic pain.
(6) Migraines.
(7) Alcohol use disorder.
(8) Tobacco use disorder.
(b) In conducting a clinical study under this section, a research institution that receives a grant under this chapter shall do the following:
(1) Include veterans and first responders in the study sample.
(2) Evaluate and determine whether psilocybin is an effective treatment for mental health and other medical conditions described in subsection (a).
(3) Compare the efficacy of psilocybin as a treatment for mental health and other medical conditions described in subsection (a) with the efficacy of other current treatment options for mental health and other medical conditions described in subsection (a).
(4) Before entering the study, require each participant to undergo a mental health evaluation.
As added by P.L.152-2024, SEC.4. Amended by P.L.213-2025, SEC.126.
Ind. Code § 12-21-9-8 Report
Sec. 8. After a research institution that receives a grant under this chapter completes and finalizes a study under this chapter, a research institution shall prepare and submit a report summarizing the results of the study and any recommendations for legislation to the following:
(1) The interim study committee on public health, behavioral health, and human services established by IC 2-5-1.3-4 in an electronic format under IC 5-14-6.
(2) The Indiana department of health.
(3) The division.
As added by P.L.152-2024, SEC.4.
Ind. Code § 12-21-9-9 Process to administer fund; applications
Sec. 9. Not later than July 1, 2024, the division shall establish a process to administer the fund and process applications under this chapter.
As added by P.L.152-2024, SEC.4.
Source: Open US Law by Vaquill AI (CC BY 4.0)URL: https://iga.in.gov/laws/2026/ic/titles/12Fetched: 10/17/2026